چکیده (انگلیسی):

Strongyloidiasis is a life-threatening parasitic infection, especially in immunosuppressed
patients, with death often occurring within several days. The disease has a worldwide distribution
and is endemic in tropical and subtropical regions. Therefore, this study was conducted to
investigate seroepidemiology of Strongyloides infection amongst immunocompromised patients
in Southwest Iran. This cross-sectional study was conducted amongst a population of
immunocompromised patients who were referred to health care or hospital referral centres
in Ahvaz, Southwest Iran. Serum samples were tested by an enzyme immunoassay for
anti-IgG Strongyloides antibody. Anti-Strongyloides stercoralis antibody was detected in 39 of
270 immunocommpromised cases, yielding a prevalence of 14.4%. No significant differences
were indicated in terms of gender, age, or type of immunocompromised disorder with
anti-Strongyloides stercoralis antibody levels. In conclusion, our results demonstrated high
seroepidemiology of infection with this parasite in the region. Therefore, it appears immunocompromised
patients should be tested for this infection using sensitive tests. However, current
research underscores that strongyloidosis must not be neglected, and further assessments in
high risk population are warranted.
© 2016 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).